[
  {
    "ts": null,
    "headline": "Edwards Lifesciences Corp. stock underperforms Friday when compared to competitors",
    "summary": "Edwards Lifesciences Corp. stock underperforms Friday when compared to competitors",
    "url": "https://finnhub.io/api/news?id=2bddc0c23b1328738ca6f263739e1cd0f30eba0e93e157edc4855681f379e7bf",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732899360,
      "headline": "Edwards Lifesciences Corp. stock underperforms Friday when compared to competitors",
      "id": 131784040,
      "image": "",
      "related": "EW",
      "source": "MarketWatch",
      "summary": "Edwards Lifesciences Corp. stock underperforms Friday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=2bddc0c23b1328738ca6f263739e1cd0f30eba0e93e157edc4855681f379e7bf"
    }
  },
  {
    "ts": null,
    "headline": "EW Investors Have Opportunity to Lead Edwards Lifesciences Corporation Securities Fraud Lawsuit with the Schall Law Firm",
    "summary": "LOS ANGELES, Nov. 29, 2024 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Edwards Lifesciences Corporation ...",
    "url": "https://finnhub.io/api/news?id=390fbeaa9cdc9ca1c494761246072f8b066aac142485cd37001d727a7ca1e09a",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732874472,
      "headline": "EW Investors Have Opportunity to Lead Edwards Lifesciences Corporation Securities Fraud Lawsuit with the Schall Law Firm",
      "id": 131706885,
      "image": "",
      "related": "EW",
      "source": "Finnhub",
      "summary": "LOS ANGELES, Nov. 29, 2024 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Edwards Lifesciences Corporation ...",
      "url": "https://finnhub.io/api/news?id=390fbeaa9cdc9ca1c494761246072f8b066aac142485cd37001d727a7ca1e09a"
    }
  },
  {
    "ts": null,
    "headline": "Allspring Disciplined U.S. Core Fund Q3 2024 Quarterly Review",
    "summary": "For the three-month period, financials, health care, and materials detracted from relative performance. Read more here.",
    "url": "https://finnhub.io/api/news?id=69f24b70afa66b46d6634a907f2362a3deb29b29432f75249dec7c840a5a1f80",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732872600,
      "headline": "Allspring Disciplined U.S. Core Fund Q3 2024 Quarterly Review",
      "id": 131706750,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2172612792/image_2172612792.jpg?io=getty-c-w1536",
      "related": "EW",
      "source": "SeekingAlpha",
      "summary": "For the three-month period, financials, health care, and materials detracted from relative performance. Read more here.",
      "url": "https://finnhub.io/api/news?id=69f24b70afa66b46d6634a907f2362a3deb29b29432f75249dec7c840a5a1f80"
    }
  },
  {
    "ts": null,
    "headline": "Balancing Innovation And Public Health: Third-Party Interests In The UPC's Landmark Ruling Of Edwards Lifesciences Vs. Meril",
    "summary": "In a landmark decision delivered on November 15, 2024, the Unified Patent Court's Local Division in Munich ruled in favor of Edwards Lifesciences Corporation in a patent infringement case against...",
    "url": "https://finnhub.io/api/news?id=00fbebfedb98a8044bf4643d990f6212290cdd59dcd5554ce4638030bddfa7e6",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732842847,
      "headline": "Balancing Innovation And Public Health: Third-Party Interests In The UPC's Landmark Ruling Of Edwards Lifesciences Vs. Meril",
      "id": 131700280,
      "image": "",
      "related": "EW",
      "source": "Finnhub",
      "summary": "In a landmark decision delivered on November 15, 2024, the Unified Patent Court's Local Division in Munich ruled in favor of Edwards Lifesciences Corporation in a patent infringement case against...",
      "url": "https://finnhub.io/api/news?id=00fbebfedb98a8044bf4643d990f6212290cdd59dcd5554ce4638030bddfa7e6"
    }
  },
  {
    "ts": null,
    "headline": "Janus Henderson Global Life Sciences Diversified ADR Managed Account Q3 2024 Commentary",
    "summary": "The Janus Henderson Global Life Sciences Diversified ADR Managed AccountÂ Portfolio returned 5.74% (gross) for Q3 2024. Click here to read the full commentary.",
    "url": "https://finnhub.io/api/news?id=d13820debe5090781df5f64d03a4e6366609fc54e420fcea29eb851f7981fff8",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732841400,
      "headline": "Janus Henderson Global Life Sciences Diversified ADR Managed Account Q3 2024 Commentary",
      "id": 131700113,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1633433467/image_1633433467.jpg?io=getty-c-w1536",
      "related": "EW",
      "source": "SeekingAlpha",
      "summary": "The Janus Henderson Global Life Sciences Diversified ADR Managed AccountÂ Portfolio returned 5.74% (gross) for Q3 2024. Click here to read the full commentary.",
      "url": "https://finnhub.io/api/news?id=d13820debe5090781df5f64d03a4e6366609fc54e420fcea29eb851f7981fff8"
    }
  }
]